Participants received either three 500-mg capsules of rapidly dissolving chitosan (LipoSan Ultra, Vanson Inc.) or placebo twice daily.
Calorie and dietary fat intake were assessed, as well as body weight, BMI, waist-to-hip ratio, and fecal fat ex- cretion.
Ten patients, most of whom were noncompliant, dropped out of the study.
At the completion of the study, mean weight had decreased 1 kg in the treatment group and increased 1.5 kg in the placebo group (p < 0.005); BMI decreased significantly in the treatment group.
A small, nonsignificant increase in fecal fat elimi- nation occurred in the treatment group. Adverse effects in the treatment group included gastrointestinal discomfort, flatulence, and stool bulkiness.
Participants received either three 500-mg capsules of rapidly dissolving chitosan (LipoSan Ultra, Vanson Inc.) or placebo twice daily. Calorie and dietary fat intake were assessed, as well as body weight, BMI, waist-to-hip ratio, and fecal fat ex- cretion. Ten patients, most of whom were noncompliant, dropped out of the study. At the completion of the study, mean weight had decreased 1 kg in the treatment group and increased 1.5 kg in the placebo group (p < 0.005); BMI decreased significantly in the treatment group. A small, nonsignificant increase in fecal fat elimi- nation occurred in the treatment group. Adverse effects in the treatment group included gastrointestinal discomfort, flatulence, and stool bulkiness.
การแปล กรุณารอสักครู่..